Association between antenatal corticosteroids use and perinatal mortality among preterm singletons and twins in Mwanza, Tanzania: an observational study. Issue 4 (7th April 2022)

• Record Type: Journal Article
• Authors: Mwita, Stanley; Kamala, Benjamin Anathory; Konje, Eveline; Ambrose, Emmanuela Eusebio; Izina, Angelina; Chibwe, Elieza; Kongola, Gilbert; Dewey, Deborah
• Is Part Of: BMJ open. Volume 12:Issue 4(2022)
• Publication Date: 2022-04-07
• Subjects: NEONATOLOGY -- Fetal medicine -- Maternal medicine -- PERINATOLOGY -- Respiratory infections; Medicine -- Research -- Periodicals; 610.72
• DOI: 10.1136/bmjopen-2021-059030
• Languages: English
• ISSNs: 2044-6055

Abstract

Abstract : Objectives: To examine the association between antenatal corticosteroids (ACS) use and perinatal mortality in singletons and twins delivered before 35 weeks of gestation. Design: Secondary analysis of data from an observational prospective chart review study that investigated if exposure to ACS was associated with lower rates of perinatal mortality in preterm infants. Setting: This study was conducted in four hospitals located in Mwanza region, Tanzania. Participants: The study population included all preterm singletons and twins delivered at these hospitals between 24 weeks 0 days and 34 weeks 6 days of gestation from July 2019 to February 2020. Outcome measures: The primary outcome was perinatal mortality; the secondary outcome was respiratory distress syndrome (RDS). Results: The study included 844 singletons and 210 twin infants. Three hundred and fourteen singletons (37.2%) and 52 twins (24.8%) were exposed to at least one dose of ACS. Adjusted multivariate analyses revealed that among singletons' exposure to ACS was significantly associated with a lower likelihood of perinatal mortality, adjusted relative risk (aRR) 0.30 (95% CI 0.22 to 0.40) and RDS, aRR 0.92 (95% CI 0.87 to 0.97). In twin infants, exposure to ACS was associated with a reduced risk of RDS only, aRR 0.87 (95% CI 0.78 to 0.98). Conclusion: The use of ACS between 24 weeks 0 days and 34 weeks 6 days of gestation in both singletons and twins in low-resource settings is associated with positive infant outcomes. No adverse effects were noted. Further research that examines the benefits of ACS for twin infants is needed.